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Abstract
Background
Familial aggregation and segregation analysis studies have provided evidence
of a genetic basis for esophageal adenocarcinoma (EAC) and its premalignant
precursor, Barrett’s esophagus (BE). We aim to demonstrate the utility of
linkage analysis to identify the genomic regions that might contain the
genetic variants that predispose individuals to this complex trait (BE and
EAC).
Methods
We genotyped 144 individuals in 42 multiplex pedigrees chosen from 1000 sin-
gly ascertained BE/EAC pedigrees, and performed both model-based and
model-free linkage analyses, using S.A.G.E. and other software. Segregation
models were fitted, from the data on both the 42 pedigrees and the 1000 pedi-
grees, to determine parameters for performing model-based linkage analysis.
Model-based and model-free linkage analyses were conducted in two sets of
pedigrees: the 42 pedigrees and a subset of 18 pedigrees with female affected
members that are expected to be more genetically homogeneous. Genome-wide
associations were also tested in these families.
Results
Linkage analyses on the 42 pedigrees identified several regions consistently sug-
gestive of linkage by different linkage analysis methods on chromosomes 2q31,
12q23, and 4p14. A linkage on 15q26 is the only consistent linkage region
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identified in the 18 female-affected pedigrees, in which the linkage signal is
higher than in the 42 pedigrees. Other tentative linkage signals are also
reported.
Conclusion
Our linkage study of BE/EAC pedigrees identified linkage regions on chromo-
somes 2, 4, 12, and 15, with some reported associations located within our link-
age peaks. Our linkage results can help prioritize association tests to delineate
the genetic determinants underlying susceptibility to BE and EAC.
Introduction
National statistics estimate 18,140 new cases of esophageal
cancer, the majority adenocarcinomas, in 2014 (Siegel
et al. 2014). The incidence of esophageal adenocarcinoma
(EAC) in the United States has increased dramatically in
the past four decades, especially in white males (Blot
et al. 1991; Pera et al. 1993; Devesa et al. 1998; Pohl and
Welch 2005; Siegel et al. 2014). The prognosis remains
poor, with a 5-year survival below 20% (Siegel et al.
2014). Almost all EACs originate in Barrett’s epithelium,
a premalignant condition in which normal stratified squa-
mous epithelium is replaced by metaplastic specialized
intestinal type columnar epithelium (Haggitt et al. 1978;
Hameeteman et al. 1989; Reid et al. 1992; Cameron et al.
1995; Hirota et al. 1999; Ruol et al. 2000; Spechler 2002;
Sharma et al. 2004). We, and others, originally recognized
that Barrett’s esophagus (BE) and EAC aggregate in a
proportion of families (Crabb et al. 1985; Prior and
Whorwell 1986; Jochem et al. 1992; Eng et al. 1993;
Fahmy and King 1993; Poynton et al. 1996; Chak et al.
2002, 2006). Because BE and EAC are epidemiologically
similar and there is evidence that nearly all EACs arise in
Barrett’s epithelium, we have considered BE and EAC to
be part of a single binary trait termed familial Barrett’s
esophagus (FBE) (Haggitt et al. 1978; Cameron et al.
1995; Hirota et al. 1999; Ruol et al. 2000).
A few linkage analyses of BE, EAC, or gastroesophageal
reflux disease (GERD) have been published, but they are
in relatively small to moderate-sized samples. Hu et al.
(2000) found linkage evidence of pediatric GERD for a
locus on chromosome 13q14 in five families, but Oren-
stein et al. (2001, 2002) excluded linkage at this locus in
a linkage study of six infantile GERD families. Orloff
et al. (2011) studied BE/EAC in 31 sib pairs (21 concor-
dant-affected and 11 discordant sibling pairs) by model-
free linkage, and reported linkage to three genes MSR1
(8p), ASCC1 (10q), and CTHRC1 (8q). Our initial studies
of FBE determined that families with three or more
affected members develop esophageal cancer at an earlier
age compared to families with only one or two affected
members, suggesting a genetic basis for this complex trait
(Chak et al. 2006, 2009). Furthermore, segregation analy-
sis of singly ascertained families provided evidence against
a sporadic environmental model and supported a genetic
basis for FBE (Sun et al. 2010). The results of the segrega-
tion analysis led us to conduct a linkage study in 42 pedi-
grees to identify genomic regions that might contain
genetic variants that predispose individuals to develop BE
and EAC.
Methods
Data
Pedigree accrual and trait definition
The multi-center methodology for approaching probands
and accruing FBE pedigrees has been previously described
(Chak et al. 2006; Sun et al. 2010). Recruitment occurred
at eight hospitals during variable periods over the past
9 years. The FBE study was approved by the institutional
review board for human investigation at each participat-
ing hospital and registered on clinicaltrials.gov
(NCT00288119).
A questionnaire that collects data on relevant covariates
is administered to affected probands and all family mem-
bers who consent to participate. A diagnosis of BE or
EAC is confirmed by review of endoscopy and pathology
records, and is defined as affected in our study (Chak
et al. 2002, 2006). This definition of the affected agrees
with a report that BE and EAC have high genetic correla-
tion (rg = 1.0) (Ek et al. 2013). The definition of the EAC
phenotype requires the presence of adenocarcinoma on
biopsy taken from a mass that predominantly involves
the tubular esophagus, and the definition of BE requires
the endoscopic appearance of columnar mucosa in the
tubular esophagus with a biopsy from that area demon-
strating intestinal metaplasia. Biopsies showing intestinal
metaplasia from an irregular Z line or the gastroe-
sophageal junction are not considered part of the trait.
Individuals without a history of BE or EAC are defined as
unaffected.
We thus obtained a set of data with 1000 singly ascer-
tained Barrett’s esophagus pedigrees comprising 10,594
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individuals that was used to estimate the genetic mode of
inheritance of FBE. The dataset used here is a corrected
and expanded version of the data that were analyzed by
Sun et al. (2010). Clinical covariate data are missing from
family members who declined participation, family mem-
bers who did not complete the clinical questionnaire, and
those who are deceased. From these, 42 informative mul-
tiplex pedigrees were chosen that comprise in total 1132
individuals with disease status available, and 144 members
with blood samples available were genotyped using the
Illumina GoldenGate Human Linkage V Panel. There
were 5687 autosomal SNPs genotyped. Although 37 of
them have a missing rate >0.05 (which were not located
in the linkage regions that we identified), because their
missing genotypes could be inferred from their relatives
this was done, and they were not excluded from the link-
age analyses. The sample call rates are >0.95 for all sam-
ples, so all the samples were used in the analysis.
Relationship and Mendelian inconsistencies were checked
using the genome-wide SNPs with the programs
RELTEST and MARKERINFO in the S.A.G.E. package
(http://darwin.cwru.edu/sage/). Fourteen relative pairs
that were identified as unrelated and two full sib pairs
identified as half sibs were accordingly corrected. There
were 395 SNPs that have Mendelian inconsistencies and
they were automatically excluded from the analyses. After
relationship correction, the genotyped pedigrees include
78 affected and 66 unaffected individuals, comprising 111
sib pairs, 10 half sib pairs, 18 avuncular pairs, and nine
cousin pairs.
Segregation models
To find appropriate models for model-based linkage anal-
ysis, we fitted segregation models using the program SEG-
REG in S.A.G.E. 6.3. This was done on both the 1000
singly ascertained pedigrees with 10,594 individuals and
the 42 linkage informative pedigrees with 1132 individu-
als. We fitted two types of statistical segregation models:
the finite polygenic mixed model (FPMM) (Fernando
et al. 1994; Lange 1997) and the multivariate logistic
model (MLM) (Karunaratne and Elston 1998), which
assume that the genetic locus has two susceptibilities,
transmitted in either a dominant or recessive mode of
inheritance. In fitting the FPMM model, we included a
polygenic component in the model. In fitting the MLM
model, we assumed no residual associations between fam-
ily members because of the theoretical difficulty this
entails (Karunaratne and Elston 1998). Two covariates –
sex and founder status – are available for all the
genotyped individuals in the linkage pedigrees, and for
model-based linkage analysis we included these two vari-
ables as covariates of the genotype susceptibilities.
In order to adjust for ascertainment, in fitting the seg-
regation models to the 1000 pedigrees we assumed single
ascertainment; when fitting models to the 42 pedigrees,
we not only assumed single ascertainment, but also speci-
fied a population prevalence constraint, assuming an
average population prevalence of 1% for BE/EAC (Ron-
kainen et al. 2005; Zagari et al. 2008). The rationale for
constraining the prevalence is that single ascertainment
cannot fully adjust for how the 42 multiplex pedigrees
were ascertained, and using a population prevalence con-
straint in the pedigree likelihood function, instead of the
higher prevalence of familial BE in BE patients (Chak
et al. 2006), helps better estimate the trait allele frequency
in founders of the pedigrees (Sun et al. 2012).
Linkage analyses
Among the 42 pedigrees containing individuals genotyped
for linkage, there were 18 pedigrees that include at least
one affected female. Because BE/EAC is less prevalent in
females, these 18 pedigrees are expected to be more genet-
ically homogeneous. The following analyses were therefore
separately performed on the 42 pedigrees and the subset
of 18 pedigrees.
Model-based linkage analyses
Using the dominant and recessive models estimated for
the 42 linkage pedigrees, we performed both multipoint
and single marker linkage analysis for the autosomal data
with the programs MLOD and LODLINK, respectively, of
the S.A.G.E. 6.3 package. The SNPs used for the multi-
point linkage were thinned to have minor allele frequency
(MAF) ≥ 0.2 and the intervals between any two consecu-
tive SNPs at least 0.2 cM. The single marker model-based
linkage analysis was performed for all the SNPs.
Model-free linkage analyses
Successively using the programs FREQ, GENIBD, and SIB-
PAL in the S.A.G.E. program package, allele frequencies
and sibpair identity by descent (IBD) were estimated for all
the SNPs and single marker model-free linkage analysis was
performed. By using the W4 option in SIBPAL, the opti-
mally weighted average of the squared sibpair trait sum and
squared sibpair trait difference (Shete et al. 2003) was
regressed on the sibpair IBD sharing for each SNP. To be
comparable to the model-based linkage, sex was included
in the regression model as a binary covariate (sibpairs con-
cordant or discordant for sex). For SNPs with nominal
P < 0.05, empirical P-values were evaluated by permuta-
tion, the number of permutations determined for the
P-values to be within 20% of their true values with 95%
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confidence, up to 100,000 permutations. Because the per-
mutation test currently in SIBPAL can lead to inflated sig-
nificance of very small P-values, especially in larger sibships
(Shete et al. 2003), we devised a more appropriate permu-
tation test (described in the Supplementary materials) that
in most cases increased the P-value: this P-value (or equiva-
lent lod) is used here whenever it was found to be larger
than the asymptotic P-value.
Association analysis
Association tests were also performed for each SNP in the
linkage panel, separately using the 42 pedigrees and the
18 female-affected pedigrees. In order to account for
familial correlations, this analysis was performed using
the program ASSOC in S.A.G.E. The association model in
ASSOC can include both a polygenic variance component
and a common sibship variance. However, both these two
variance components converged to 0 on testing 95% of
the SNPs, and only one of them could be estimated for
the remaining 5% of the SNPs. In testing the association,
each SNP was coded in three ways – dominant, recessive,
or additive. Sex and founder status were included as
covariates of FBE (i.e., of the logit of FBE). For each
SNP, the minimum association P-value among the three
tests (additive, dominant or recessive) less than 0.01 by a
likelihood ratio test is reported.
Results
Segregation models
On fitting the FPMM model with 1 polygenic locus, we
found that – on the basis of Akaike’s A information
criterion (AIC) – using the 1000 pedigrees or the 42 linkage
pedigrees, the best-fitting model was found to be a domi-
nant model (the heterozygous genotype and the homozy-
gous minor allele genotype have higher disease risk); on
fitting the MLM model, using either dataset the best-fitting
model was a recessive model (the minor allele homozygous
genotype has higher risk) (Table 1). In addition to the
mode of transmission, the penetrance probabilities esti-
mated from the 1000 pedigrees are also very close to those
from the 42 pedigrees (Table S1); however, the estimated
trait locus allele frequencies from the two sets of pedigrees
are very different, the one from the 42 linkage pedigrees
having a much higher susceptibility allele frequency. This is
expected because the 42 linkage pedigrees were ascertained
from the 1000 pedigrees for having more affected family
members. In view of this, we used both the dominant and
recessive models fitted to the 42 linkage pedigrees, allowing
for single ascertainment and using a prevalence constraint,
for model-based linkage analyses of these 42 genotyped
pedigrees (Table 1, models 1 and 2).
Linkage analyses
The potential genetic heterogeneity of BE/EAC and rela-
tively small sample size make it difficult to find good evi-
dence of linkage; we therefore performed multiple linkage
analyses and summarize here the most consistent results.
The regions or positions that are identified by at least
two linkage analysis methods, or by one linkage analysis
method, but also show some possible evidence of associa-
tion, are highlighted in the Tables. Full detailed results
identified by any of the analyses are reported in the
Tables S2 and S3.
Table 1. Segregation models estimated from the 42 linkage pedigrees and the 1000 pedigrees.
Parameters (standard errors)1
42 pedigrees2 1000 pedigrees3
1. Dominant (FPMM) 2. Recessive (MLM) 3. Dominant (FPMM) 4. Recessive (MLM)
bAA 3.25  0.10 0.844 2.26  0.20 0.63  0.50
bAB 3.25  0.10 35.364 2.26  0.20 5.17  0.21
bBB 34.40 35.364 5.72  0.25 5.17  0.21
Sex 2.52  0.08 2.09  0.53 1.39  0.20 1.47  0.24
Founder 3.22  0.10 2.69  0.79 1.61  0.28 1.70  0.33
Polygenic variance 5.50  0.17 1.06  0.27
qA 0.05  0.01 0.21  0.02 0.005  0.002 0.07  0.02
AIC 573.75 586.85 1559.49 1740.22
1All parameter estimates are on the logit scale except for qA, the susceptibility allele; b is the logit of susceptibility (probability of ever having
disease) for individuals with a given genotype (AA, AB, or BB); sex and founder are two mean-centered covariates of the (logit of) susceptibility.
2Adjusting for single ascertainment and using a prevalence constraint.
3Adjusting for single ascertainment.
4Flat or near-flat likelihood in the region of the estimates.
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Linkage analysis of the 42 pedigrees
The regions and locationsmost suggestive of linkage that were
identified in the 42 pedigrees by at least two analyses are seen
in Table 2; they are located on chromosomes 2, 4, 8, and 12.
Model-based linkage analyses
Using the recessive model, there were some linkage
(lod > 3) or suggestive linkage (lod > 2) regions by sin-
gle-marker or multipoint linkage analysis (Fig. 1A). Using
the dominant model, there was no suggestive linkage by
single-marker linkage analysis. However, multipoint link-
age analysis found many suggestive linkage regions
(Fig. 2A, Table S2), and the dominant model led to an
overall higher lod profile: the average lod under the dom-
inant model was three lods higher than that under the
recessive model. Therefore, only those regions under this
model with lod > 3 are discussed here.
Under the recessive model, a wide, consistent linkage
region was identified by both single-marker and multi-
point linkage analyses on chromosome 2q31
(174–190 cM), within which three SNPs have lod > 2 by
single-marker analysis (Table 2). This region was also
supported by a multipoint linkage under the dominant
model (lod > 4). A linkage region on chromosome 12
(110–120 cM) was identified by multipoint linkage under
both dominant and recessive models, with lods of 3.9 and
3.3, respectively, at 113 cM (Figs. 1A and 2A, Table 2);
we did not find any single-marker linkage in this region.
The linkage region on chromosome 4 (48–59 cM) was
identified by multipoint linkage under the dominant model
(lod = 3.2), and a SNP with single-marker linkage was
identified in this region under the recessive model
(lod = 2.0). Another region on this chromosome, at
73.2 cM, was identified by single marker linkage under the
recessive model. A region on chromosome 8 at 99–125 cM
was identified by model-based multipoint linkage analyses
under the dominant model (lod = 3.8 at 121 cM).
Model-free linkage analysis
Single-marker model-free linkage in the 42 pedigrees identi-
fied one SNP having permutation P value < 0.0012 (or
log10(P) > 2.92), which corresponds to lod > 2 (Table S2).
However, this SNP identified by model-free linkage is
not consistent with any other linkage analyses we performed.
Linkage analysis of the 18 female-affected
pedigrees
In the 18 female-affected pedigrees, the only region that
was consistently identified to have suggestive linkage by
two analyses is on chromosome 15q26, identified by both
the single-marker and multipoint linkage analyses under
the recessive model, with lods of 2.45 and 2.98, respec-
tively, at 128.8 cM (Table 3). This region was also identi-
fied in the 42 pedigrees by multipoint linkage under the
recessive model (Table S2), but the linkage signal in the
18 pedigrees is 0.6 lods higher.
Estimating the proportion of linked pedigrees
using Merlin
We also performed multipoint model-based linkage using
MERLIN (Abecasis et al. 2002), in order to estimate the
proportion of linked pedigrees in our dataset. MERLIN
gave linkage results similar to MLOD, estimating the pro-
portion of linked pedigrees to be 88% at the linkage
region on chromosome 2 in the 42 pedigrees, but only
74%, in the 18 female-affected pedigrees. The proportion
of linked pedigrees at the chromosome 15 region was
72% in the 42 pedigrees, but increased to 100% in the 18
female-affected pedigrees.
Association analysis
Not surprisingly, there were no SNPs reaching genome-
wide association significance by the association tests,
using either the 42 pedigrees or the 18 female affected
pedigrees (Figures S1 and S2). However, association tests
with the 42 pedigrees identified 4 SNPs that showed some
possible evidence of association in the linkage regions on
chromosomes 2 (two SNPs in 2q31 had P ≤ 0.007), 4 (a
SNP at 72.8 cM had P = 0.008), and 8 (a SNP with
P = 0.002) (Table 2), although none of them would be
significant when adjusting for multiple testing. No associ-
ation was identified in the 18 female-affected pedigrees at
the linkage region identified by these pedigrees on
chromosome 15.
Summary of linkage and association
analyses
In the 42 pedigrees, the linkage regions consistently iden-
tified by two or more linkage analyses are on chromo-
somes 2q31, 4p14, and 12q23. The wide linkage region on
chromosome 2q31 (174–190 cM) was identified by multi-
ple linkage analyses (single-marker and multipoint linkage
analyses under recessive and dominant models), and two
SNPs in this region also showed suggestive association.
The linkage region on chromosome 12q23 (110–120 cM)
was identified by multipoint linkage under both domi-
nant and recessive models. The region on 4p14 (48–
59 cM) was identified by multipoint linkage under the
dominant model, but with a single SNP linkage under the
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recessive model. Furthermore, chromosome 4q (72–
73 cM) and 8q22 (99–125 cM) were identified in the 42
pedigrees by one of the linkage analyses and showed some
evidence of association.
In the 18 female-affected pedigrees, the only region
identified by two or more linkage analyses was on chro-
mosome 15q26 under the recessive model. This region
was also identified in the 42 pedigrees, but the linkage
was stronger in the subset of 18 pedigrees.
Discussion
In this study, we performed extensive linkage analyses on
Barrett’s esophagus (BE) and its associated adenocarcino-
mas on 42 multiplex pedigrees and a subset of them, 18
female-affected pedigrees. The best fitting inhertiance
models were dominant or recessive, depending on the pen-
etrance model we used and whether it included a polygenic
component. By model-based linkage analyses under the
dominant or recessive models, regions on chromosomes
2q, 4p, and 12q were identified to have consistent linkage
by at least two linkage analyses in the 42 pedigrees, and a
narrow region on chromosome 15 was identified by
model-based linkage analyses under the recessive model in
the 18 female-affected pedigrees. Some other regions or
SNPs on chromosome 4q and 8q were also identified by
linkage and association analyses. All these linkage regions
or positions are candidates for further study or verification
and potential genetic testing in BE/EAC families.
It could be that the 42 pedigrees are not genetically differ-
ent from the 18 female affected pedigrees and only appear
to be so by chance. However, the proportion of linked pedi-
grees at the two linkage regions on chromosome 2 and
chromosome 8 estimated by MERLIN suggests that, for the
chromosome 2 linkage region, the 18 female-affected pedi-
grees are more genetically heterogeneous than the whole set
of 42 pedigrees. On the other hand, for the linkage on chro-
mosome 15, the 18 female-affected pedigrees are more
genetically homogeneous than the 42 pedigrees.
In the previous segregation analysis, we found that BE
was transmitted in a dominant mode by fitting the
FPMM model (Sun et al. 2010). In this study, we also
found that when we fit the FPMM model, using either
the 1000 pedigrees or the 42 genotyped pedigrees, the best
fitting model is a dominant model. But when we fit an
MLM model without assuming residual associations
between family members, the best fitting model is a reces-
sive one. Using the appropriate genetic model in model-
based linkage analysis will increase the power to detect
linkage. Our linkage results suggest our data comprise a
combination of heterogeneous BE pedigrees, which would
explain why one cannot clearly distinguish the mode of
inheritance when assuming a single-locus model.Ta
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There are some reported associations located in the
linkage regions that we have identified. McElholm et al.
(2010) studied IGF Axis Polymorphisms and reported
SNPs in three genes (IGF1, IGF1R, and GHR) to be
associated with BE, EAC, or reflux esophagitis. The asso-
ciated SNPs in two of the genes, IGF1 and IGF1R, are
Figure 1. Model-based linkage under the recessive model (model 2 in Table 1). (A) The 42 pedigrees. (B) The 18 female-affected pedigrees. The
red line is multipoint linkage by MLOD, the blue points are for single-marker linkage by LODLINK. The X-axis is the genetic position in cM, the
Y-axis is the lod.
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near the linkage peaks we have identified. The associated
SNP rs6214 in IGF1 that was reported by McElholm
et al. is located in our linkage region on chromosome
12q23, 685 kb from the peak SNP rs3205421; but in
another association study of BE, in a cohort of 1852
cases and 5172 controls, rs6214 did not reach genome-
wide significance (Palles et al. 2015). The associated
SNPs (rs2715425 and rs4966044) in IGF1R are located in
Figure 2. Model-based linkage under the dominant model (model 1 in Table 1). (A) The 42 pedigrees. (B) The 18 female affected pedigrees. The
red line is multipoint linkage by MLOD, the blue points are for single-marker linkage by LODLINK. The X-axis is the genetic position in cM, the
Y-axis is the lod.
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the linkage region on chromosome 15, 840 kb from the
peak SNP rs2045112. Moreover, Orloff et al. (2011)
reported linkage on 8q21 (rs3097418) and association on
8q22, which are both located in our linkage regions. The
associated SNP rs3098233 they found on 8q22, in the
CTHRC1 gene, is 66 kb from the SNP rs2131858 in our
linkage region (Table 2). Furthermore, Palles et al.
(2015) reported two SNPs associated with BE by meta-
analysis. One is located on chromosome 2p24 (rs3072)
near the first linkage peak we identified under the reces-
sive model (Fig. 1A, Table S2), 320 kb from SNP
rs952275, which has a lod of 2.44. The other one,
(rs2701108) on chromosome 12, is 13 Mb from the peak
of linkage we identified at 12q23; it is within the linkage
region, with a lod of 1.55 at that location under the
dominant model. These authors also detected a SNP in
their discovery phase, rs10083033, which is 3.79 Mb
(4 cM) from the linkage peak we found on 12q23. These
reported associations support the evidence from our
linkage findings. Furthermore, although there is no
reported association located in the linkage region on
chromosome 2q31 that we identified by multiple linkage
analyses, prior studies have reported somatic mutations
in genes mapping to this region in Barrett’s adenocarci-
nomas (Walch et al. 2000; El-Rifai et al. 2001; Bandla
et al. 2012). In addition, in the Genotype-Tissue Expres-
sion (GTEx) database (GTEx Consortium, 2015), we
found that rs711814 in the chromosome 2 linkage region
is a significant cis-eQTL (P = 0.0000031) that regulates
the KIAA1715 expressed in esophagus mucosa, and the
peak SNP rs3205421 in the chromosome 12 region is a
significant cis-eQTL (P = 2 9 1013) that regulates the
GNPTAB gene expressed in esophagus muscularis
(http://www.gtexportal.org/home/eqtls/). These reported
functional effects further support our findings.
In this study, we genotyped all individuals with blood
samples available. This is not an ideal study with a suffi-
ciently large sample size to come up with results that can
stand on their own. Nevertheless, the corroborative results
already found in recent genome-wide association studies
demonstrate that thorough linkage analyses, even on non-
ideal data, can help focus the search for causal genes. On
the reasonable assumption that it is genetically more
homogeneous, we specifically studied linkage in the subset
of 18 female-affected pedigrees. It is always possible that
females have some gender-specific protective mechanisms
from developing Barrett’s esophagus, but the definitive
reason for such a gender difference is unclear. An ideal
linkage study would include more covariates, such as BMI
and gastroesophageal reflux symptoms, easily done with
the software we used. If, for example, evidence for linkage
changes when BMI is included as a covariate, a genome-
wide association study of this obesity-related disease
would locate the risk variants by addressing the impact of
BMI on the association(Schaid et al. 2003). Moreover, a
denser genotyping array could have enabled us to identify
more signals or provide a more precise location for the
linked regions and association signals.
We anticipate that further studies with dense SNPs
could refine our linkages and associations and verify our
finding on chromosome 2q31, as well as in the other
regions on chromosomes 4p, 4q, and 8q. Note that, given
a linkage signal, the significance level of a verification
association study would not need to reach a genome-wide
significance level. For the linkage region on chromosome
2, for example, which is about 18 cM long (i.e., a fraction
of about 18/3000 of the whole genome), if we assume that
5 9 108 is the appropriate level for genome-wide signifi-
cance, a P-value of 5 9 108 9 3000/18, or about 105,
would be sufficient to allow for the multiple testing to
validate our findings. Hence, we recommend the results
of genome-wide association studies be reevaluated in one
of two ways. First, focusing on the limited number of
linkage regions reported here, we could calculate the
Table 3. Linkage (LODLINK, MLOD, SIBPAL) and association (ASSOC) results identified using 18 female-affected pedigrees with evidence of sug-
gestive linkage or association.
Chr Position (cM)
Model-based linkage
Model-free linkage Association
Recessive Dominant
LODLINK (lod > 2) MLOD (lod > 2)
LODLINK
(lod > 2)
MLOD
(lod > 3)
SIBPAL (log10
(P) > 2.92)
ASSOC
(P < 0.01)
Position SNP Lod Position SNP Lod Lod Lod log10(P) P-value
15 128–130
(15q26)
128.83 rs2045112 2.445 128.83 rs2045112 2.979 ≤1.49 ≤2.41 ≤0.93 ≥0.57
15 130.14 rs7183000 2.309
Note: the regions or SNPs in bold are those identified by at least two linkage analyses. Regions or SNPs with suggestive linkage (lod > 2, or
log10(P > 2.92) or association (unadjusted P < 0.01) are reported; but, for multipoint linkage under the dominant model, only those with
lod > 3 are reported because this model produces an overall higher average lod than the other linkage results. If no suggestive signal in a region
is identified by an analysis, the largest signal by the analysis in the region is reported.
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equivalent number of independent SNPs in those regions
(Galwey 2009) to determine an appropriate P-value and
reexamine previous association study results. Second,
investigate most of the linkage regions we have suggested
where no associations have yet been found, in a new set
of association data, but again with a much smaller multi-
ple-testing burden.
The rapidly rising incidence of EAC over the past four
decades is undoubtedly related to an uncharacterized
environmental factor. We propose that this change in the
environmental factor is interacting with an underlying
complex genetic susceptibility, which is contributing to
this rising incidence of BE and EAC, and the genes
involved will be easier to find if the linkage results we
report here are taken into account.
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